L3Harris Receives Landmark PAC‑3 MSE Propulsion Contract to Power America's Arsenal of Freedom

L3Harris received an undefinitized $4.7 billion, seven-year contract award from Lockheed Martin to produce propulsion systems for PAC-3 MSE interceptors. The award is L3Harris' largest PAC-3 propulsion contract to date and aligns with its long-term framework agreement with the Department of War, materially strengthening its multiyear defense backlog and revenue visibility.

Analysis

The economic significance for LHX is less the headline value than the conversion of its Aerojet integration into a recurring, sole-source production franchise. At an implied roughly $670M annual run-rate, the program can add about 3% to LHX revenue, but the higher-value outcome is improved solid-rocket-motor utilization: fixed-cost absorption could drive segment-margin upside once production cadence stabilizes over the next 12-24 months. This also strengthens LHX's position for adjacent interceptor, hypersonic and tactical-missile propulsion awards, where qualified domestic capacity remains the binding constraint.

LMT receives strategic supply-chain de-risking rather than a material direct earnings uplift. A more reliable motor flow supports PAC-3 delivery timing and reduces the risk that missile backlog converts more slowly than investors expect; RTX is the more relevant indirect beneficiary through broader air-defense demand, while NOC's missile franchise faces a relative capacity disadvantage if LHX locks up incremental propellant, casing and energetics inputs. The second-order issue is supplier concentration: any disruption at LHX propulsion facilities would now have amplified consequences across a high-priority program.

The award is not yet equivalent to fully funded, fixed-economics backlog. Definitization terms, escalation provisions, working-capital requirements and capital expenditures determine whether revenue growth translates to accretive FCF; investors should not assume mature-program margins at launch. Near-term upside is likely limited after an initial LHX reaction, but 1-3 month catalysts are contract definitization and FY guidance commentary; 6-18 month upside requires evidence of sustained margin expansion and additional capacity-backed awards. Falsify the thesis if LHX discloses material launch losses, raises propulsion capex without FCF offset, or fails to lift its medium-term segment margin/organic-growth outlook.

Key Decisions for Investors

• Accumulate LHX on post-news weakness rather than chase the opening move; target a 12-18 month long thesis around propulsion utilization and follow-on demand, with a risk limit if management indicates program margins below corporate average or incremental FCF conversion is delayed beyond 2027.
• Express relative value as long LHX / short LMT in equal dollar amounts for the next 3-6 months: LHX has materially greater earnings sensitivity, while LMT's benefit is principally execution-risk reduction. Exit if LHX's valuation premium expands without a guidance increase or if definitization is delayed.
• Maintain a watch alert, not a fresh position, on RTX and NOC: missile-production cadence, Department of Defense supplemental funding, and disclosed solid-motor capacity additions are the needed data to determine whether supply constraints create a tradable relative-performance gap.
• Before adding exposure, require disclosure of contract pricing and working-capital terms at the next LHX earnings call; an undefinitized award can increase reported backlog visibility while leaving economics and cash timing unresolved.